Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-06-21

AUTHORS

Martina Wieser, Stefan Sauerland, Dirk Arnold, Wolff Schmiegel, Anke Reinacher-Schick

ABSTRACT

BackgroundThe role of peri-operative chemotherapy in patients with resected stage IV colorectal cancer (CRC) remains to be defined. This study was aimed at evaluating the effectiveness of peri-operative chemotherapy in patients with resected stage IV CRC by performing a meta-analysis of relevant trials.MethodsWe performed a literature search to identify trials comparing patients with stage IV CRC receiving peri-operative chemotherapy and surgery with patients undergoing surgery alone. The hazard ratio (HR) was estimated to assess any survival advantage of peri-operative chemotherapy.ResultsEight trials conducted on a total of 1174 patients were identified by a literature search. In these trials, HR estimates suggested that peri-operative chemotherapy yielded no survival advantage over surgery alone (HR, 0.94; 95%CI, 0.8-1.10; p = 0.43). In a subset analysis on intra-arterial chemotherapy alone, no survival benefit was evident (HR, 1.0; 95% CI, 0.84-1.21; p = 0.96; I2 = 30%), whereas in the trials involving systemic chemotherapy, the difference between the groups approached statistical significance (HR, 0.74; 95% CI, 0.53-1.04; p = 0.08; I2 = 0%). Both peri-operative treatment groups had a significant recurrence-free survival benefit (HR, 0.78; 95% CI, 0.65-0.95; P = 0.01 for hepatic arterial infusion; and HR, 0.75; 95% CI, 0.62-0.91; p = 0.003 for systemic therapy). The toxicities of chemotherapy were acceptable in most trials.ConclusionsThis is the first meta-analysis demonstrating the importance of peri-operative chemotherapy in the treatment of resected stage IV CRC. Although the results must be carefully interpreted because of some limitations, critical issues were identified that must be resolved by future studies. More... »

PAGES

309

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2407-10-309

DOI

http://dx.doi.org/10.1186/1471-2407-10-309

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1028347950

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20565923


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Meta-Analysis as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Knappschaftskrankenhaus Bochum Langendreer, University of Bochum, Bochum, Germany", 
          "id": "http://www.grid.ac/institutes/grid.5570.7", 
          "name": [
            "Department of Internal Medicine, Knappschaftskrankenhaus Bochum Langendreer, University of Bochum, Bochum, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wieser", 
        "givenName": "Martina", 
        "id": "sg:person.0700442405.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700442405.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute for Research in Operative Medicine, University of Witten/Herdecke, Cologne, Germany", 
          "id": "http://www.grid.ac/institutes/grid.412581.b", 
          "name": [
            "Institute for Research in Operative Medicine, University of Witten/Herdecke, Cologne, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sauerland", 
        "givenName": "Stefan", 
        "id": "sg:person.01240721774.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240721774.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology and Oncology, University of Halle, Germany", 
          "id": "http://www.grid.ac/institutes/grid.9018.0", 
          "name": [
            "Department of Hematology and Oncology, University of Halle, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arnold", 
        "givenName": "Dirk", 
        "id": "sg:person.01270303133.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270303133.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute for Clinical-Oncological Studies within P.U.R.E, University Bochum, Bochum, Germany", 
          "id": "http://www.grid.ac/institutes/grid.5570.7", 
          "name": [
            "Department of Internal Medicine, Knappschaftskrankenhaus Bochum Langendreer, University of Bochum, Bochum, Germany", 
            "Institute for Clinical-Oncological Studies within P.U.R.E, University Bochum, Bochum, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schmiegel", 
        "givenName": "Wolff", 
        "id": "sg:person.0731736602.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731736602.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute for Clinical-Oncological Studies within P.U.R.E, University Bochum, Bochum, Germany", 
          "id": "http://www.grid.ac/institutes/grid.5570.7", 
          "name": [
            "Department of Internal Medicine, Knappschaftskrankenhaus Bochum Langendreer, University of Bochum, Bochum, Germany", 
            "Institute for Clinical-Oncological Studies within P.U.R.E, University Bochum, Bochum, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reinacher-Schick", 
        "givenName": "Anke", 
        "id": "sg:person.01073166374.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073166374.14"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s004230050199", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005575327", 
          "https://doi.org/10.1007/s004230050199"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00044011-200020050-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039478054", 
          "https://doi.org/10.2165/00044011-200020050-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10434-001-0347-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015538540", 
          "https://doi.org/10.1007/s10434-001-0347-3"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-06-21", 
    "datePublishedReg": "2010-06-21", 
    "description": "BackgroundThe role of peri-operative chemotherapy in patients with resected stage IV colorectal cancer (CRC) remains to be defined. This study was aimed at evaluating the effectiveness of peri-operative chemotherapy in patients with resected stage IV CRC by performing a meta-analysis of relevant trials.MethodsWe performed a literature search to identify trials comparing patients with stage IV CRC receiving peri-operative chemotherapy and surgery with patients undergoing surgery alone. The hazard ratio (HR) was estimated to assess any survival advantage of peri-operative chemotherapy.ResultsEight trials conducted on a total of 1174 patients were identified by a literature search. In these trials, HR estimates suggested that peri-operative chemotherapy yielded no survival advantage over surgery alone (HR, 0.94; 95%CI, 0.8-1.10; p = 0.43). In a subset analysis on intra-arterial chemotherapy alone, no survival benefit was evident (HR, 1.0; 95% CI, 0.84-1.21; p = 0.96; I2 = 30%), whereas in the trials involving systemic chemotherapy, the difference between the groups approached statistical significance (HR, 0.74; 95% CI, 0.53-1.04; p = 0.08; I2 = 0%). Both peri-operative treatment groups had a significant recurrence-free survival benefit (HR, 0.78; 95% CI, 0.65-0.95; P = 0.01 for hepatic arterial infusion; and HR, 0.75; 95% CI, 0.62-0.91; p = 0.003 for systemic therapy). The toxicities of chemotherapy were acceptable in most trials.ConclusionsThis is the first meta-analysis demonstrating the importance of peri-operative chemotherapy in the treatment of resected stage IV CRC. Although the results must be carefully interpreted because of some limitations, critical issues were identified that must be resolved by future studies.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1471-2407-10-309", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "keywords": [
      "stage IV colorectal cancer", 
      "peri-operative chemotherapy", 
      "colorectal cancer", 
      "hazard ratio", 
      "survival benefit", 
      "survival advantage", 
      "recurrence-free survival benefit", 
      "literature search", 
      "resectable liver metastases", 
      "intra-arterial chemotherapy", 
      "toxicity of chemotherapy", 
      "systemic chemotherapy", 
      "liver metastases", 
      "relevant trials", 
      "randomized trials", 
      "subset analysis", 
      "chemotherapy", 
      "treatment groups", 
      "most trials", 
      "patients", 
      "systematic review", 
      "surgery", 
      "trials", 
      "statistical significance", 
      "HR estimates", 
      "cancer", 
      "future studies", 
      "treatment", 
      "group", 
      "metastasis", 
      "MethodsWe", 
      "ConclusionsThis", 
      "total", 
      "study", 
      "toxicity", 
      "benefits", 
      "review", 
      "search", 
      "differences", 
      "significance", 
      "role", 
      "effectiveness", 
      "ratio", 
      "importance", 
      "analysis", 
      "results", 
      "limitations", 
      "advantages", 
      "estimates", 
      "critical issue", 
      "issues"
    ], 
    "name": "Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials", 
    "pagination": "309", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1028347950"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2407-10-309"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20565923"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2407-10-309", 
      "https://app.dimensions.ai/details/publication/pub.1028347950"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_516.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1471-2407-10-309"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-10-309'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-10-309'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-10-309'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2407-10-309'


 

This table displays all metadata directly associated to this object as RDF triples.

187 TRIPLES      21 PREDICATES      86 URIs      75 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2407-10-309 schema:about N1a8994878dc246ce85c790976220a1e3
2 N2ab81bad01214b8a90b31f84bb447db8
3 Na3b7ef26f17b4e4ab4f92c5e135f8164
4 Nab01bd2478ef4dbd861bfe83607ffbc3
5 Nac6d6ea310ec444d8e76fb6ce46fbcef
6 Nad9653b1649a4e72ab462eeb801e8ea3
7 Nb5a270ea79154aa399e7397b0c27344b
8 anzsrc-for:11
9 anzsrc-for:1112
10 schema:author N00a6f411f1d44df6b65ee60063d69ee0
11 schema:citation sg:pub.10.1007/s004230050199
12 sg:pub.10.1007/s10434-001-0347-3
13 sg:pub.10.2165/00044011-200020050-00002
14 schema:datePublished 2010-06-21
15 schema:datePublishedReg 2010-06-21
16 schema:description BackgroundThe role of peri-operative chemotherapy in patients with resected stage IV colorectal cancer (CRC) remains to be defined. This study was aimed at evaluating the effectiveness of peri-operative chemotherapy in patients with resected stage IV CRC by performing a meta-analysis of relevant trials.MethodsWe performed a literature search to identify trials comparing patients with stage IV CRC receiving peri-operative chemotherapy and surgery with patients undergoing surgery alone. The hazard ratio (HR) was estimated to assess any survival advantage of peri-operative chemotherapy.ResultsEight trials conducted on a total of 1174 patients were identified by a literature search. In these trials, HR estimates suggested that peri-operative chemotherapy yielded no survival advantage over surgery alone (HR, 0.94; 95%CI, 0.8-1.10; p = 0.43). In a subset analysis on intra-arterial chemotherapy alone, no survival benefit was evident (HR, 1.0; 95% CI, 0.84-1.21; p = 0.96; I2 = 30%), whereas in the trials involving systemic chemotherapy, the difference between the groups approached statistical significance (HR, 0.74; 95% CI, 0.53-1.04; p = 0.08; I2 = 0%). Both peri-operative treatment groups had a significant recurrence-free survival benefit (HR, 0.78; 95% CI, 0.65-0.95; P = 0.01 for hepatic arterial infusion; and HR, 0.75; 95% CI, 0.62-0.91; p = 0.003 for systemic therapy). The toxicities of chemotherapy were acceptable in most trials.ConclusionsThis is the first meta-analysis demonstrating the importance of peri-operative chemotherapy in the treatment of resected stage IV CRC. Although the results must be carefully interpreted because of some limitations, critical issues were identified that must be resolved by future studies.
17 schema:genre article
18 schema:isAccessibleForFree true
19 schema:isPartOf N9581aac80cd14bcb8686fe1e5c950c29
20 Nc0ba005fcd904afc9571c02af590b8a3
21 sg:journal.1024632
22 schema:keywords ConclusionsThis
23 HR estimates
24 MethodsWe
25 advantages
26 analysis
27 benefits
28 cancer
29 chemotherapy
30 colorectal cancer
31 critical issue
32 differences
33 effectiveness
34 estimates
35 future studies
36 group
37 hazard ratio
38 importance
39 intra-arterial chemotherapy
40 issues
41 limitations
42 literature search
43 liver metastases
44 metastasis
45 most trials
46 patients
47 peri-operative chemotherapy
48 randomized trials
49 ratio
50 recurrence-free survival benefit
51 relevant trials
52 resectable liver metastases
53 results
54 review
55 role
56 search
57 significance
58 stage IV colorectal cancer
59 statistical significance
60 study
61 subset analysis
62 surgery
63 survival advantage
64 survival benefit
65 systematic review
66 systemic chemotherapy
67 total
68 toxicity
69 toxicity of chemotherapy
70 treatment
71 treatment groups
72 trials
73 schema:name Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials
74 schema:pagination 309
75 schema:productId N40141e3ec7e34ae5a6b16b9d0116f662
76 N4b35444c465145beb9ca404fb5ab0a8a
77 N7087c69e8188413c8e1cb5bb8260f98d
78 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028347950
79 https://doi.org/10.1186/1471-2407-10-309
80 schema:sdDatePublished 2022-08-04T16:58
81 schema:sdLicense https://scigraph.springernature.com/explorer/license/
82 schema:sdPublisher N292267eb64bb40e0b4da73162c5abd44
83 schema:url https://doi.org/10.1186/1471-2407-10-309
84 sgo:license sg:explorer/license/
85 sgo:sdDataset articles
86 rdf:type schema:ScholarlyArticle
87 N00a6f411f1d44df6b65ee60063d69ee0 rdf:first sg:person.0700442405.73
88 rdf:rest N85aec6d5749b4f23b31e8e4b1420f351
89 N1a8994878dc246ce85c790976220a1e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Antineoplastic Agents
91 rdf:type schema:DefinedTerm
92 N292267eb64bb40e0b4da73162c5abd44 schema:name Springer Nature - SN SciGraph project
93 rdf:type schema:Organization
94 N2ab81bad01214b8a90b31f84bb447db8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Liver Neoplasms
96 rdf:type schema:DefinedTerm
97 N40141e3ec7e34ae5a6b16b9d0116f662 schema:name pubmed_id
98 schema:value 20565923
99 rdf:type schema:PropertyValue
100 N4b35444c465145beb9ca404fb5ab0a8a schema:name dimensions_id
101 schema:value pub.1028347950
102 rdf:type schema:PropertyValue
103 N7087c69e8188413c8e1cb5bb8260f98d schema:name doi
104 schema:value 10.1186/1471-2407-10-309
105 rdf:type schema:PropertyValue
106 N85aec6d5749b4f23b31e8e4b1420f351 rdf:first sg:person.01240721774.82
107 rdf:rest Nb0a73349728a469589ec2527ef936b9f
108 N9581aac80cd14bcb8686fe1e5c950c29 schema:issueNumber 1
109 rdf:type schema:PublicationIssue
110 Na3b7ef26f17b4e4ab4f92c5e135f8164 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Colorectal Neoplasms
112 rdf:type schema:DefinedTerm
113 Na91561ed1a1b4c11a6426f9f456f5cf2 rdf:first sg:person.0731736602.46
114 rdf:rest Nac948965eed1420aa4044e23686070c5
115 Nab01bd2478ef4dbd861bfe83607ffbc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Randomized Controlled Trials as Topic
117 rdf:type schema:DefinedTerm
118 Nac6d6ea310ec444d8e76fb6ce46fbcef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Meta-Analysis as Topic
120 rdf:type schema:DefinedTerm
121 Nac948965eed1420aa4044e23686070c5 rdf:first sg:person.01073166374.14
122 rdf:rest rdf:nil
123 Nad9653b1649a4e72ab462eeb801e8ea3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Treatment Outcome
125 rdf:type schema:DefinedTerm
126 Nb0a73349728a469589ec2527ef936b9f rdf:first sg:person.01270303133.74
127 rdf:rest Na91561ed1a1b4c11a6426f9f456f5cf2
128 Nb5a270ea79154aa399e7397b0c27344b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Humans
130 rdf:type schema:DefinedTerm
131 Nc0ba005fcd904afc9571c02af590b8a3 schema:volumeNumber 10
132 rdf:type schema:PublicationVolume
133 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
134 schema:name Medical and Health Sciences
135 rdf:type schema:DefinedTerm
136 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
137 schema:name Oncology and Carcinogenesis
138 rdf:type schema:DefinedTerm
139 sg:journal.1024632 schema:issn 1471-2407
140 schema:name BMC Cancer
141 schema:publisher Springer Nature
142 rdf:type schema:Periodical
143 sg:person.01073166374.14 schema:affiliation grid-institutes:grid.5570.7
144 schema:familyName Reinacher-Schick
145 schema:givenName Anke
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073166374.14
147 rdf:type schema:Person
148 sg:person.01240721774.82 schema:affiliation grid-institutes:grid.412581.b
149 schema:familyName Sauerland
150 schema:givenName Stefan
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240721774.82
152 rdf:type schema:Person
153 sg:person.01270303133.74 schema:affiliation grid-institutes:grid.9018.0
154 schema:familyName Arnold
155 schema:givenName Dirk
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270303133.74
157 rdf:type schema:Person
158 sg:person.0700442405.73 schema:affiliation grid-institutes:grid.5570.7
159 schema:familyName Wieser
160 schema:givenName Martina
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700442405.73
162 rdf:type schema:Person
163 sg:person.0731736602.46 schema:affiliation grid-institutes:grid.5570.7
164 schema:familyName Schmiegel
165 schema:givenName Wolff
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0731736602.46
167 rdf:type schema:Person
168 sg:pub.10.1007/s004230050199 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005575327
169 https://doi.org/10.1007/s004230050199
170 rdf:type schema:CreativeWork
171 sg:pub.10.1007/s10434-001-0347-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015538540
172 https://doi.org/10.1007/s10434-001-0347-3
173 rdf:type schema:CreativeWork
174 sg:pub.10.2165/00044011-200020050-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039478054
175 https://doi.org/10.2165/00044011-200020050-00002
176 rdf:type schema:CreativeWork
177 grid-institutes:grid.412581.b schema:alternateName Institute for Research in Operative Medicine, University of Witten/Herdecke, Cologne, Germany
178 schema:name Institute for Research in Operative Medicine, University of Witten/Herdecke, Cologne, Germany
179 rdf:type schema:Organization
180 grid-institutes:grid.5570.7 schema:alternateName Department of Internal Medicine, Knappschaftskrankenhaus Bochum Langendreer, University of Bochum, Bochum, Germany
181 Institute for Clinical-Oncological Studies within P.U.R.E, University Bochum, Bochum, Germany
182 schema:name Department of Internal Medicine, Knappschaftskrankenhaus Bochum Langendreer, University of Bochum, Bochum, Germany
183 Institute for Clinical-Oncological Studies within P.U.R.E, University Bochum, Bochum, Germany
184 rdf:type schema:Organization
185 grid-institutes:grid.9018.0 schema:alternateName Department of Hematology and Oncology, University of Halle, Germany
186 schema:name Department of Hematology and Oncology, University of Halle, Germany
187 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...